OncLive

Education ▼

Register | Login

Conference Coverage

Attend An Event

State of the Science Summit

Regional Seminar Series

PER Conferences

OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis

SPECIALTY TOPICS

CURRENTLY VIEWING
All Specialties

Multiple Myeloma

Immuno-Oncology News

Gynecologic Oncology

Gastrointestinal Cancer

Colorectal Cancer

Prostate Cancer

Neoadjuvant HER2+

<< View More Conferences

2018 State of the Science Summit on Hematologic Malignancies in Cleveland

Oncology Conference Multimedia

View more videos >>

Dr. Dean on the Evolution of Treatment Approaches in MCL

Dr. Dean on the Evolution of Treatment Approaches in MCL

Dr. Valent on MRD Negativity in Multiple Myeloma

Dr. Valent on MRD Negativity in Multiple Myeloma

Dr. Carraway on Predisposition to Acute Myeloid Leukemia

Dr. Carraway on Predisposition to Acute Myeloid Leukemia

Oncology Conference Articles

Targeted Agents Beyond Ruxolitinib Necessary in Evolving MPN Paradigm

Targeted Agents Beyond Ruxolitinib Necessary in Evolving MPN Paradigm

Aaron Gerds, MD, discusses the activity and drawbacks with current systemic agents in myeloproliferative neoplasms.

Combinations May Confer Benefit in MDS Management

Combinations May Confer Benefit in MDS Management

Mikkael A. Sekeres, MD, discusses the characteristics of myelodysplastic syndrome and the evolving armamentarium of treatment.

Zonder Addresses Unanswered Questions in Newly Diagnosed Myeloma

Zonder Addresses Unanswered Questions in Newly Diagnosed Myeloma

Jeffrey A. Zonder, MD, discusses triplet regimens in multiple myeloma and patient eligibility for clinical trials.

OncLive SAP

FDA Approvals in Myeloma and aTTP, Priority Review Designations in RCC and HNSCC, and More

Trending Now

PARP Inhibitors Hold Promise in mCRPC and Biallelic DNA Repair Gene Defects

Novel Agents Spark New Approaches for Triple-Negative Breast Cancer

Pembrolizumab/Cabozantinib Combo Is Well Tolerated, Shows Activity in Metastatic RCC

Pembrolizumab Shows Promising Activity in Non-Clear Cell RCC

Covering Every Angle of Oncology Practice. Click a cover below, to view more.

Publication Bottom Border

Dermatologists in Cancer Care®

Milestones In Medicine

Rapid Reviews in Oncology®

Urologists in Cancer Care

Oncology Business News

Contemporary Radiation Oncology

Oncology Nursing News

Oncology Fellows

Precision Medicine in Oncology

Invited Presentations

Oncology Treatment Pathways®

CURE Rare Cancers-Summer 2017 Issue

HEAL Summer 2017

Extraordinary Healers Vol. 11

Border Publication

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Oncology Nursing News
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
TargetedOnc

OncLive Resources

Articles
Blogs
Conference Coverage
OncLive TV
Peer Exchange
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Careers
Contact Us
Forgot Password
Press Releases
Privacy Policy
Terms & Conditions

iTunes

YouTube

Google Plus

Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-939-0221

Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.

x